There may not be enough time to make it to our target price of $82 for Cardinal Health (CAH) when our target holding period for it expires on Feb. 22, but the quarterly earnings results the company released today gave it a strong shove in that direction, rising above… Read More

Somewhat surprisingly for a company that deals in lethal weapons, gun maker Sturm, Ruger & Co. (RGR) has been one of the tamest stocks in our portfolio. Since adding it on Nov. 15, its share price has deviated less than 5% in either direction. All that may change on Feb. 22, when the… Read More

Few recommendations have ignited as much “fan mail” as my addition of CVS to the portfolio two weeks ago. And with its next quarterly earnings report coming out later this week, I have a funny feeling there will be more on my way if the news is not good. But… Read More

GILD spent the first three weeks of January drifting lower until catching an updraft after Trump’s inauguration. That is somewhat ironic, since it is Trump who was viewed as the greatest threat to drug companies such as Gilead. Compounding matters for the healthcare sector is Trump’s disjointed approach to repealing… Read More

If our thesis for owning USNA is correct, then we should see its share price rebound when the company releases its quarterly earnings report after the market close on February 7. I don’t expect to see a marked improvement in its past operating results from its current restructuring plan yet, but… Read More

Unlike many other retailers that have taken it in the shins lately after reporting dismal holiday sales, BBY actually gained ground in January dues to its strong performance in November and December. That’s good news since we added it on January 5, and we are expecting another surge after the… Read More

Our timing on homebuilder D.R. Horton was pretty good; after adding it to our portfolio on January 18 below $29, it ran up above $31 the following week when the company released quarterly results that beat estimates for both sales and earnings. DHI reported a 20% increase in total revenue over… Read More

We added CATO to our portfolio on February 1, the day before it announced sales results for January. Although same-store sales declined by 15%, the stock rallied on the news since it was not as bad as feared. The entire retail sector has taken a pounding recently, but the… Read More

If enough people are temporarily ignoring conventional metrics when making buy and sell decisions, then we can make money from those decisions if we correctly identify stocks those investors are likely to embrace next. Read More

There wasn’t much activity in AFSI last month. Other than issuing a press release two weeks ago announcing the date it will release its fourth quarter earnings report (February 27), there was no news of any sort issued by or about AmTrust to push its stock one way or the… Read More